Cambrex was approached by a top 10 Asian pharmaceutical company looking to partner with a contract manufacturing organization (CMO) with commercial manufacturing capabilities and expertise, mid- to large-scale cGMP assets and exemplary quality systems and US FDA track record. The requirement was to find a cost effective process to produce the API for a new drug.
Cambrex had previously been working with the emerging company which initially developed the drug, so proactively approached the customer with innovative ideas for a new cost effective method. The original chemistry included a high number of chemical and purification steps and Cambrex believed a more efficient method was achievable. The customer felt that Cambrex had the necessary know-how, scale-up and commercial production expertise to meet its requirements.